These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 3874906)
21. Genetic analysis of indefinite division in human cells: evidence for a common immortalizing mechanism in T and B lymphoid cell lines. Goletz TJ; Robetorye S; Pereira-Smith OM Exp Cell Res; 1994 Nov; 215(1):82-9. PubMed ID: 7957685 [TBL] [Abstract][Full Text] [Related]
22. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes. Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301 [TBL] [Abstract][Full Text] [Related]
23. [Monoclonal antibodies produced by human-human hybridomas]. Chida J Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711 [TBL] [Abstract][Full Text] [Related]
24. Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells. Gallagher G; Stimson WH Immunology; 1984 Dec; 53(4):611-21. PubMed ID: 6209205 [TBL] [Abstract][Full Text] [Related]
25. Human T-cell hybrids secreting lymphokines: effect of different parent cell clones of the human T-cell acute lymphoblastoid leukaemia line CCRF-CEM. Gallagher G; Stimson WH Scand J Immunol; 1986 May; 23(5):617-22. PubMed ID: 3486467 [TBL] [Abstract][Full Text] [Related]
26. Efforts to produce human cytotoxic T-cell hybridomas by electrofusion and PEG fusion. Gravekamp C; Santoli D; Vreugdenhil R; Collard JG; Bolhuis RL Hybridoma; 1987 Apr; 6(2):121-33. PubMed ID: 3494659 [TBL] [Abstract][Full Text] [Related]
27. Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype. Barsky SH; Sternlicht MD; Safarians S; Nguyen M; Chin K; Stewart SD; Hiti AL; Gray JW Oncogene; 1997 Oct; 15(17):2077-91. PubMed ID: 9366525 [TBL] [Abstract][Full Text] [Related]
28. New human fusion partners, ICLU-B, -T, -E for making human hybridomas derived from various immunological cells. Kawahara H; Maeda-Yamamoto M; Suzuki M; Hakamata K Hum Antibodies; 1999; 9(2):89-94. PubMed ID: 10405829 [TBL] [Abstract][Full Text] [Related]
29. Lymphokine production by human T cell hybridomas. Le J; Vilcek J; Sadlik JR; Cheung MK; Balazs I; Sarngadharan MG; Prensky W J Immunol; 1983 Mar; 130(3):1231-5. PubMed ID: 6401782 [TBL] [Abstract][Full Text] [Related]
30. Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers. Delvig AA; Koumaré B; Glaser RW; Wang JF; Jahn S; Achtman M Hum Antibodies Hybridomas; 1995; 6(2):42-6. PubMed ID: 7492749 [TBL] [Abstract][Full Text] [Related]
31. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes. Martin GM; Ogburn CE; Au K; Disteche CM J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936 [TBL] [Abstract][Full Text] [Related]
32. A new method for the development of human T-T cell hybrids without the use of HAT medium. Platsoucas CD; Calvelli TA; Kunicka JA Hybridoma; 1987 Dec; 6(6):589-603. PubMed ID: 3501764 [TBL] [Abstract][Full Text] [Related]
33. Functional characterization of cell hybrids generated by induced fusion of primary porcine mesenchymal stem cells with an immortal murine cell line. Islam MQ; Ringe J; Reichmann E; Migotti R; Sittinger M; da S Meirelles L; Nardi NB; Magnusson P; Islam K Cell Tissue Res; 2006 Oct; 326(1):123-37. PubMed ID: 16741712 [TBL] [Abstract][Full Text] [Related]
34. Unequal segregation of parental chromosomes in embryonic stem cell hybrids. Matveeva NM; Pristyazhnyuk IE; Temirova SA; Menzorov AG; Vasilkova A; Shilov AG; Smith A; Serov OL Mol Reprod Dev; 2005 Jul; 71(3):305-14. PubMed ID: 15806559 [TBL] [Abstract][Full Text] [Related]
35. [FISH-analysis of regional replication in homologous chromosomes in hybrid cells obtained by fusion of embryonic stem cells with somatic cells]. Podriadchikova OL; Pristiazhniuk IE; Matveeva NM; Serov OL Tsitologiia; 2009; 51(6):500-5. PubMed ID: 19637753 [TBL] [Abstract][Full Text] [Related]
36. Failure of infinite life span human cells from different immortality complementation groups to yield finite life span hybrids. Ryan PA; Maher VM; McCormick JJ J Cell Physiol; 1994 Apr; 159(1):151-60. PubMed ID: 8138583 [TBL] [Abstract][Full Text] [Related]
37. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique. Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268 [TBL] [Abstract][Full Text] [Related]
38. Invasiveness of T-cell hybridomas in vitro and their metastatic potential in vivo. Roos E; La Rivière G; Collard JG; Stukart MJ; De Baetselier P Cancer Res; 1985 Dec; 45(12 Pt 1):6238-43. PubMed ID: 3877565 [TBL] [Abstract][Full Text] [Related]
39. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE; Spits H J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458 [TBL] [Abstract][Full Text] [Related]
40. Development of in vivo derived diploid and tetraploid pig embryos in a modified medium NCSU 37. Procházka R; Vodicka P; Zudová D; Rybár R; Motlík J Theriogenology; 2004 Jul; 62(1-2):155-64. PubMed ID: 15159110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]